Rocket Lab is the second largest US satellite launch provider, poised for significant growth with its upcoming Neutron rocket, expected to start commercial operations next year. The success and timely launch of Neutron are critical, as delays could increase dilution risk due to the equity component of Rocket Lab's recent acquisition of Iridium and refinancing needs. The Iridium acquisition transforms Rocket Lab into a fully integrated space company with global coverage and immediate profitability benefits. Despite current stock weakness presenting a buying opportunity, the key risk remains the execution of the Neutron rocket, which will impact both valuation and dilution.
